NAMSA has completed the acquisition of WuXi AppTec's US medical device testing operations as of February 28, 2025. This merger combines significant expertise in medical device biological safety testing. With the acquisition, NAMSA strengthens its capabilities, expanding its team and lab capacity. This move aligns with NAMSA's strategy to enhance its service offerings to manufacturers in the medical technology sector.
Who to call at Namsa, and when
When Namsa changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
An alert the day Namsa raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Namsa, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Namsa. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Namsa
Location
Toledo, Ohio, United States
About
Helping medical device Sponsors improve healthcare since 1967, NAMSA is the world’s only 100% medical device-focused, full continuum Contract Research Organization (CRO). Driven by its global expertise and in-depth therapeutic knowledge, NAMSA is dedicated to accelerating medical device product development, offering only the most proven solutions to move Clients’ products through the development lifecycle efficiently and cost-effectively. From medical device testing; regulatory, reimbursement and quality consulting; and clinical research services, NAMSA is the industry’s premier, trusted partner for successful development and commercialization outcomes. Web: namsa.com
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Namsa makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.